Trade of the House

← All trades

BUY ABT · Shelley M Capito

Abbott Laboratories

B

Deliberate position with a committee link

Signal score 68 / 100 — how much this looks like a deliberate, informed position rather than routine portfolio activity.
Inside their committee's jurisdiction
32/32
Isolated decision, not a bulk rebalance
19/22
Small, thinly-followed company
Nobody needs inside information to buy a mega-cap.
2/10
Committee chair or ranking member
8/8
A name they had never held before
A first purchase is a decision; the ninth purchase of the same holding is a standing order.
8/8
Member's own account
0/8
Unusually large for this member
Against their own median trade, not an absolute threshold - and capped, because trades beyond 3x did worse, not better.
0/6
Position size
0/3
Leveraged instrument (option)
0/3

A high grade is not an allegation. Every input is public, and buying into an industry you work on daily is ordinary expertise. What the trade actually returned is deliberately excluded from this score and shown separately below.

It is also not a forecast. Measured across every settled trade, A-graded ones did not beat E-graded ones to any significant degree — the method page prints the table. This score says a trade looks like a decision rather than administration, and nothing more.

The filing it came from

3rd member to buy this in 60 days Also bought by Dean Phillips, Gilbert Cisneros in the 60 days before this filing became public. Three or more members clustering on one name has gone with +12.61% twelve-month alpha against +4.78% for a lone buyer — context, not a recommendation.

filed in 57 days Past the 45 days the STOCK Act allows, so the trade was months old before it was public.

How this position ended

SoldHeldReturn vs S&P
24 Feb 2025 1819 d +89.0% -25.6% part of the holding

Closed by the member. What the member did afterwards, for context. The strategy does not act on it: exiting when members disclose selling cost 6.50 points against holding the full twelve months.

This one is in the strategy. It is an in-remit purchase, so it enters the book on the first market open after the filing appeared and is held for 365 days regardless of what the member does next.

This filing disclosed 4 transactions in total, of which 4 share this trade date (03 Mar 2020).

Filed 29 Apr 2020 · source PDF

Same day: JPMMSFTJNJ

Price

Entry
$81.80
30 Apr 2020
Latest
$109.72
11 Aug 2026
Since entry
+34.1%
price only

52-week range $81.98 – $133.53. The marker is the entry: the first market open after this filing became public.

Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic chol…

Market cap
$193.2B
1yr target
$118
+6.8% from $110.91
Analysts
24
buy
P/E
35.9
beta 0.58
SectorHealthcare
IndustryMedical Devices
Analyst range $103 – $135
Employees122,000
InstrumentST
Jurisdiction tags healthcare

https://www.abbott.com

Inside this member's remit. Their committees cover defenseenergyhealthcareindustrialsmaterialstechnologytelecomtransportutilities

Expressing this with options

An illustration, not a recommendation: the nearest listed expiry to a twelve-month horizon, struck near the money. Chains are live — Yahoo publishes no historical chains, so this is priced today, not when the filing was made, and the move it describes may already have happened.

Loading chain…

Outcome

HeldThis tradeS&P 500Alpha
1m +3.3% +4.3% -1.0%
3m +11.0% +11.5% -0.6%
6m +15.1% +14.1% +1.1%
12m 1yr +32.7% +45.3% -12.7%
18m +43.5% +61.0% -17.5%
24m +27.3% +45.4% -18.1%
36m +26.3% +49.3% -23.0%
48m +23.6% +82.8% -59.2%
60m 5yr +55.5% +104.5% -48.9%
now 75.4 mo +34.1% +189.3% -155.2%

Measured from the first open after disclosure — the earliest anyone reading this could have acted. The highlighted now row sits at its true place in the sequence, so where it falls tells you how long the position has run. Every window has closed, so this trade is fully settled.

Other congressional trades in ABT

GradeDateMemberSideAmount
17 Jul 2026 Mike Kelly sale $1,001 - $15,000
D 08 Jul 2026 Rick Larsen sale $1,001 - $15,000
E 16 Jun 2026 Gilbert Cisneros purchase $1,001 - $15,000
E 12 Jun 2026 Richard Dean Dr McCormick purchase $1,001 - $15,000
E 12 Jun 2026 Richard Dean Dr McCormick purchase $1,001 - $15,000
D 27 May 2026 Josh Gottheimer sale partial $1,001 - $15,000
E 15 May 2026 Gilbert Cisneros sale $1,001 - $15,000
E 12 May 2026 Julie Johnson sale $1,001 - $15,000
B 16 Apr 2026 Richard W. Allen sale $15,001 - $50,000
E 27 Mar 2026 Alan Armstrong sale $15,001 - $50,000
D 24 Mar 2026 Laura Friedman exchange $1,001 - $15,000
E 19 Mar 2026 Richard Dean Dr McCormick purchase $1,001 - $15,000
E 10 Feb 2026 Gilbert Cisneros sale partial $1,001 - $15,000
B 29 Jan 2026 Thomas H. Kean Jr purchase $1,001 - $15,000
E 19 Dec 2025 Gilbert Cisneros sale partial $1,001 - $15,000
E 18 Dec 2025 Julie Johnson sale $1,001 - $15,000
B 08 Dec 2025 Julia Letlow sale $1,001 - $15,000
D 04 Dec 2025 Byron Donalds sale $1,001 - $15,000
E 04 Dec 2025 Byron Donalds sale $1,001 - $15,000
E 18 Nov 2025 Gilbert Cisneros purchase $1,001 - $15,000
E 13 Nov 2025 Julie Johnson sale partial $1,001 - $15,000
E 05 Nov 2025 Richard Dean Dr McCormick purchase $1,001 - $15,000
D 06 Oct 2025 Rick Larsen purchase $1,001 - $15,000
E 14 Aug 2025 Julie Johnson sale partial $1,001 - $15,000
B 21 Jul 2025 Thomas H. Kean Jr purchase $1,001 - $15,000